Popular Obesity Drugs Linked to Aspiration Pneumonia Following Endoscopy
RT Magazine
by RT Staff
50m ago
New research warns individuals scheduled for medical procedures to halt popular weight loss drugs like Ozempic and Wegovy prior to prevent aspiration pneumonia, a risk associated with these medications RT’s Three Key Takeaways: Glucagon-like peptide-1 receptor agonists (GLP-1RAs), including medications like Ozempic and Wegovy used for diabetes and obesity, are linked to an increased risk of aspiration pneumonia following endoscopy, as per research from Cedars-Sinai. The study, published in Gastroenterology, analyzed data from nearly 1 million de-identified US patients who underwent upper or l ..read more
Visit website
US News Reveals the 2024 Best OTC Cough, Cold, and Allergy Medicines
RT Magazine
by RT Staff
50m ago
The second annual report covers 123 product categories, including the best cough, cold, and allergy medicines available for over-the-counter use.  RT’s Three Key Takeaways: The second annual Best OTC Medicine & Health Products rankings by US News & World Report offer consumers guidance in selecting the most effective over-the-counter remedies, including cough, cold, and allergy medicines. Product categories such as allergy eye drops, oral allergy medicines, and cold medicines were evaluated, with top-ranked brands including Pataday, Zyrtec, and Sudafed. Rankings were determined t ..read more
Visit website
FDA Approves Merck’s Injection for Pulmonary Arterial Hypertension
RT Magazine
by RT Staff
22h ago
The injection on top of background therapy significantly improved exercise capacity and multiple secondary outcome measures compared to background therapy alone. The US Food and Drug Administration (FDA) has approved sotatercept-csrk (Winrevair, Merck) injection for the treatment of adults with pulmonary arterial hypertension (PAH) to increase exercise capacity, improve WHO functional class, and reduce the risk of clinical worsening events.  Winrevair was previously granted Breakthrough Therapy Designation by the FDA. Winrevair is the first FDA-approved activin signaling inhibitor therapy ..read more
Visit website
FDA Authorizes Pemgarda for COVID-19 Prevention
RT Magazine
by RT Staff
22h ago
The FDA issued Emergency Use Authorization (EUA) for Pemgarda (pemivibart) as a pre-exposure prophylaxis (PrEP) against COVID-19, according to manufacturer Invivyd Inc. RT’s Three Key Takeaways: EUA Approval for Pemgarda: Pemgarda has received EUA for PrEP of COVID-19 in adults and adolescents with moderate to severe immune compromise, providing a crucial preventive option for vulnerable populations. Novel Trial Design: Pemgarda is the first PrEP monoclonal antibody (mAb) authorized by the FDA based on a novel, rapid, and repeatable immunobridging trial design, demonstrating Invivyd’s commitm ..read more
Visit website
Federal Appeals Court Upholds FDA’s Graphic Cigarette Warnings
RT Magazine
by RT Staff
1d ago
A three-judge panel of the US Court of Appeals for the Fifth Circuit has unanimously upheld graphic health warnings on cigarette packs and advertising required under a 2020 US Food and Drug Administration (FDA) rule.  This decision reverses a ruling by a lower court judge that blocked the warnings. Rejecting tobacco industry arguments, the appellate court found that the FDA’s warnings were “factual and uncontroversial” and did not violate the First Amendment.  “This decision is an important step toward finally implementing graphic cigarette warnings in the United States, which were f ..read more
Visit website
Congress Introduces SOAR Act to Improve Supplemental Oxygen Access
RT Magazine
by RT Staff
1d ago
The Supplemental Oxygen Access Reform Act (SOAR) of 2024, designed to ease access to supplemental oxygen for Medicare beneficiaries, was introduced in the US House of Representatives by a bipartisan group of members of Congress.  The legislation, introduced by Representatives David Valadao (R-CA), Larry Bucshon, MD (R-IN), Adrian Smith (R-NE), and Julia Brownley (D-CA), is identical to S.3821 introduced by US Senators Bill Cassidy, MD (R-LA), Mark Warner (D-VA), and Amy Klobuchar (D-MN) on Feb 28. The SOAR Act would establish a new payment methodology for liquid oxygen and for supplementa ..read more
Visit website
NBRC Invests $4M into Accredited RT Programs
RT Magazine
by RT Staff
2d ago
More than 450 CoARC-accredited respiratory care educational programs will each receive $10,000 to use toward scholarships for current and future RTs. RT’s Three Key Takeaways The NBRC allocated over $4 million in scholarship funds to 450+ CoARC-accredited respiratory care programs, aiming to bolster the profession by attracting and retaining talent. Scholarship funds of $10,000 per program can be used for practice exams, recruitment activities, or classroom equipment, offering flexibility to address specific educational needs. In addition to financial support, the NBRC leads a national campai ..read more
Visit website
Certain Protein Found to Influence Allergic Asthma Effects
RT Magazine
by RT Staff
2d ago
Researchers identify a protein—Piezo1—as having a role in mitigating the effects of allergic asthma, which they say could represent a new treatment approach. Researchers have discovered that a protein called Piezo1 prevents a type of immune cell in the lung from becoming hyperactivated by allergens and that switching on Piezo1 could represent a new therapeutic approach to reducing lung inflammation and treating allergic asthma. The study by researchers at the Keck School of Medicine, University of Southern California is published in the Journal of Experimental Medicine. Type 2 innate lymphoid ..read more
Visit website
Lung Disease Tied to Higher Heart Disease Risk Regardless of Risk Factors
RT Magazine
by RT Staff
2d ago
Patients with lung disease are more likely to develop heart disease independent of any risk factors, according to new research. A new study published in Orphanet Journal of Rare Diseases looked at patients who have a rare genetic condition called Alpha-1 antitrypsin deficiency (AATD) which causes lung disease similar to COPD independently of any risk factors such as smoking or age.  More than 220 patients with AATD were recruited to the study alongside patients with COPD and a control non-lung disease population. All were assessed for present cardiovascular disease and recognized risk fac ..read more
Visit website
Glycan Discovery Holds Promise for Halting Pertussis Transmission
RT Magazine
by RT Staff
2d ago
Potential drug and vaccine strategies could target crucial glycan to fight pertussis. Researchers have identified a new complex-carbohydrate biomolecule, or glycan, that plays a key role in the nasal colonization of the Bordetella bacteria responsible for pertussis. They say the discovery could make it possible to create a new drug or vaccine that interferes with the glycan to greatly reduce or even stop ongoing Bordetella transmission. Bordetella pertussis is the cause of the respiratory infection pertussis, which is widely known as whooping cough. Today’s pertussis vaccines keep people from ..read more
Visit website

Follow RT Magazine on FeedSpot

Continue with Google
Continue with Apple
OR